AKT1 and neoplasm: Therefore, by exerting an opposite effect on different pathways—inhibiting the TGF-β and RHOA/ROCK pathways, and activating PI3K/AKT/mTOR—miR-148a causes various functional consequences: It suppresses the development of metastases and increases the sensitivity of tumor cells to chemotherapy.